Compare RFIL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RFIL | BDSX |
|---|---|---|
| Founded | 1979 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 62.5M |
| IPO Year | N/A | 2020 |
| Metric | RFIL | BDSX |
|---|---|---|
| Price | $5.78 | $5.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $9.25 | ★ $32.50 |
| AVG Volume (30 Days) | 55.3K | ★ 61.8K |
| Earning Date | 01-14-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,353,000.00 | ★ $80,173,000.00 |
| Revenue This Year | $21.53 | $20.75 |
| Revenue Next Year | $4.92 | $25.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.60 | 22.29 |
| 52 Week Low | $3.39 | $3.44 |
| 52 Week High | $9.56 | $31.00 |
| Indicator | RFIL | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 32.25 |
| Support Level | $5.54 | $5.61 |
| Resistance Level | $6.33 | $6.92 |
| Average True Range (ATR) | 0.31 | 0.53 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 23.07 | 11.58 |
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.